Hematologic Malignancy Clinical Trials in Philadelphia, Pennsylvania
6 recruitingPhiladelphia, Pennsylvania
Showing 1–6 of 6 trials
Recruiting
Phase 4
Allergy Delabeling in Antibiotic Stewardship - Intervention
Hematologic MalignancyBeta Lactam Allergy
Abramson Cancer Center at Penn Medicine3,800 enrolled1 locationNCT07133074
Recruiting
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Solid TumorHematologic MalignancyB-ALL
St. Jude Children's Research Hospital100 enrolled5 locationsNCT06579469
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Diffuse Large B Cell LymphomaHodgkin LymphomaNon-Hodgkin Lymphoma+16 more
Children's Hospital Medical Center, Cincinnati30 enrolled5 locationsNCT06131801
Recruiting
Phase 1Phase 2
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Relapsed Hematologic MalignancyRefractory Hematologic MalignancyRelapsed Primary Central Nervous System Lymphoma+1 more
Curis, Inc.152 enrolled45 locationsNCT03328078
Recruiting
Not Applicable
Home Blood Transfusions
Acute Myeloid LeukemiaHematologic MalignancyMyelodysplastic Syndromes+1 more
Thomas Jefferson University30 enrolled1 locationNCT07121140
Recruiting
Phase 1
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Hodgkin LymphomaAMLMDS+8 more
Therapeutic Advances in Childhood Leukemia Consortium54 enrolled31 locationsNCT05476770